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        Development of T lymphocytes is initiated after 
migration of bone marrow  –  derived progenitors 
into the thymus (  1  ). Thymocyte progenitors 
then diff  erentiate through a series of stages into 
mature T cells that express TCR           and have 
distinct functional properties to allow for im-
mune responses against foreign antigens while 
avoiding reactivity to self-antigens (  2  ). T cell 
precursors in the thymus are classifi  ed into four 
major populations based on expression of the 
two coreceptor molecules, CD4 and CD8. The 
most immature thymocytes, which express nei-
ther CD4 nor CD8 (double-negative [DN] 
thymocytes), are further subdivided into four 
sub    populations designated as DN1 –  DN4 based on 
expression of the CD44 and CD25 markers (  3  ). 
At the DN2 (CD44     CD25     ) and the DN3 
(CD44        CD25     ) developmental stages, precur-
sors initially rearrange and express   Tcrb   to form 
pre  –  T cell receptors (preTCRs) (  4  ). Signals 
transduced through the preTCR after success-
ful   Tcrb   rearrangement drive precursors into a 
robust proliferation phase ( 5  ). This process, named 
      selection, is followed by down-regulation of 
CD25 in DN4 cells and subsequent induction 
of CD4 and CD8 expression as cells transit to 
the double-positive (DP) stage, at which thymo-
cytes rearrange   Tcra   and express TCR           het-
erodimers that interact with peptide  –  MHC 
complexes expressed on thymic epithelial cells. 
The few cells bearing TCR           with appropriate 
avidity for peptide  –  MHC undergo positive 
selection, whereas those with lower or higher 
avidities are eliminated by apoptotic processes 
known, respectively, as   “  death by neglect  ”   and 
negative selection (  2  ). Cells with TCR          s spe-
cifi  c for MHC class I are selected to become 
CD4        CD8      single-positive (CD8SP) thymo-
cytes that give rise to cytotoxic T cells, whereas 
those with MHC class II  –  restricted receptors 
are selected to become CD4     CD8         (CD4SP) 
thymocytes and helper T cells. 
  The transcription factor ThPOK/cKrox, 
encoded by   Zbtb7b  , plays a crucial role in gen-
eration of CD4SP mature thymocytes (  6, 7  ). In 
spontaneous mutant mice with a loss of function 
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silencing that is linked to commitment to the CD8SP lineage 
(  14, 19  ), and it is expressed in CD8SP thymocytes but not in 
CD4SP thymocytes (  20  ). These fi  ndings suggest that Runx3 
is a potential key regulator for CD8SP lineage specifi  cation. 
However, it remains unclear whether Runx proteins play 
any role in the process of lineage commitment of positively 
selected thymocytes. 
  To clarify the functions of Runx proteins during T cell 
development, we analyzed thymocyte and T cell development 
in T cell lineage-specifi   c Runx1 and Runx3 conditional 
knockout mice and report that Runx1 plays an important role 
in thymocyte selection and maturation of selected T cells. 
Whereas   Runx3   inactivation at the DP stage caused a mild re-
duction in the number of CD8      mature thymocytes and 
CD8      T cells, compound mutation of   Runx1   and   Runx3   re-
sulted in a severe reduction of positively selected thymocytes 
and almost a complete loss of CD8SP mature thymocytes. 
Runx1 was found to be important for the survival of CD4 
lineage T cells, in part by regulating expression of IL-7R     . 
These results demonstrate that Runx proteins have multiple 
functions at diff  erent stages of T cell development and in 
T cell homeostasis. 
    RESULTS   
  Runx1 is required for the DN to DP transition in     TCR         
T cell development 
  We previously showed that Runx1 inactivation by the   Lck  -cre 
transgene at the DN2 and DN3 stages resulted in CD4 dere-
pression and thymic hypocellularity (  14  ). To elucidate the role 
of Runx1 in early thymocyte diff  erentiation, we performed 
a detailed analysis in   Runx1    F/F  ;  Lck  -cre mice. As a result of 
Runx1 inactivation at the DN stage, we observed a reduced 
number of DP and mature thymocytes, accompanied by a rel-
ative increase in the proportion of DN thymocytes (  Fig. 1 A 
and see Fig. 2 E  ).   Total thymocyte numbers were reduced by 
approximately sixfold compared with those in the littermate 
  Runx1    F/F   or control   Lck-cre   mice (unpublished data). At the 
DN stage, defi  ned as TCR             CD8        CD4       /lo  , we consistently 
observed accumulation of CD25  hi   DN2 and DN3 thymocytes, 
which had higher expression of CD25 than control DN2 and 
DN3 cells (  Fig. 1   A, bottom). The absolute numbers of DN2 
and DN3 thymocytes were similar between   Runx1    F/F  ;  Lck  -cre 
and control mice, suggesting that thymocyte development 
in   Runx1    F/F  ;  Lck  -cre mice was severely compromised during 
transition from the DN3 to DN4 stages (  Fig. 1, B and E  ). 
TCR           cell development in the thymus was unaff  ected in 
  Runx1    F/F  ;  Lck  -cre mice (  Fig. 1 C  ). 
  Developmental arrest at the DN3 stage often coincides 
with impaired       selection caused by either loss of rearranged 
TCR      protein expression or defects in preTCR signaling. 
To determine whether TCR      expression and/or       selec-
tion was aff   ected, staining for intracellular TCR       chain 
(icTCR     ) protein and cell-cycle analysis were performed 
(  Fig. 1, B and D  ; and not depicted). In DN thymocytes from 
control   Runx1    F/F   mice,     25% of CD25      cells expressed 
icTCR      protein, and 30% of the total DN thymocytes had 
mutation of ThPOK, termed   hd/hd   (helper-defi  cient) mice, 
all selected thymocytes diff  erentiate into the CD8SP lineage 
regardless of the MHC specifi  city of the TCR. Conversely, 
transgenic overexpression of ThPOK in DP thymocytes 
causes redirection of thymocytes selected through interaction 
of TCR and MHC class I from the CD8 to the CD4 lineage. 
The transcription factor GATA3 is also important for gen-
eration of CD4SP thymocytes (  8, 9  ). GATA3-defi  cient DP 
thymocytes fail to develop to the CD4SP stage after positive 
selection, and GATA3 overexpression blocks diff  erentiation 
of CD8SP thymocytes after positive selection by MHC class I, 
whereas misexpression of GATA3 does not result in lineage 
redirection. It remains unclear whether there is a key tran-
scription factor essential for commitment to the CD8SP lin-
eage or if CD8SP development is a default pathway that can 
be altered only when ThPOK and GATA3 are expressed. 
  Regulation of CD4 and CD8 expression is critical for 
the appropriate selection of the TCR           repertoire during 
thymocyte diff  erentiation (  10  ). Whereas the   Cd8a   and   Cd8b   
genes that encode CD8 are regulated by multiple stage-specifi  c 
enhancers during T cell development,   Cd4   is primarily regu-
lated by its unique cis-acting element, the   Cd4   silencer, lo-
cated in the fi  rst intron (  11  ). Targeted deletion of the   Cd4   
silencer resulted in CD4 derepression in DN and CD8SP 
thymocytes, indicating that the silencer is necessary for negative 
regulation of CD4 expression at both of these stages (  12  ). Inter-
estingly, conditional inactivation of the   Cd4   silencer in com-
mitted CD4        CD8      cells did not restore CD4 expression (  13  ). 
This and other results have demonstrated that the   Cd4   si-
lencer is required for the establishment but not for the main-
tenance of CD4 silencing in CD8SP cells, and that the silencing 
is maintained by epigenetic mechanisms (  12  ). Epigenetic CD4 
silencing is thus tightly linked to development of the CD8SP 
lineage of T cells. 
  We have identifi  ed the Runx proteins as factors binding 
to the   Cd4   silencer and negatively regulating CD4 expression 
in DN and CD8SP mature thymocytes (  14  ). The Runx fam-
ily of transcription factors consists of three members, Runx1/
AML1/Cbfa2/PEBP2     B, Runx2/AML3/Cbfa1/Pebp2     A, 
and Runx3/AML2/Cbfa3/Pebp2     C (  15  ). All three Runx 
proteins share a highly conserved DNA-binding   runt   domain 
and the C-terminal VWRPY motif. Association of Runx 
proteins with the common cofactor CBF      by way of the   runt   
domain increases binding to target DNA sequences. Mem-
bers of the Groucho family of corepressors associate with 
the Runx C-terminal motif, which is required for Runx3 
to mediate CD4 silencing (  16, 17  ). Runx1 and Runx3 are 
diff  erentially required for CD4 silencing at the DN and 
CD8SP stages of thymocyte diff  erentiation, respectively (  14  ). 
Runx1 also contributes to CD8 expression at the DP stage 
(  14  ), whereas Runx3 binds to CD8 enhancers (  18  ) and may 
contribute to CD8 expression in CD8SP and mature CD8 
lineage T cells. Because Runx proteins regulate CD4 and 
CD8 expression, they may also have important roles in thy-
mocyte selection and CD4 versus CD8 lineage-commitment 
processes. The Runx3 protein plays a crucial role in CD4 JEM VOL. 204, August 6, 2007 
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subsequently, to the DP stage, which caused a reduction in 
total thymocyte cellularity. 
  Runx1 is required for positive selection and maturation 
of CD4SP thymocytes 
  The block in thymocyte development in   Runx1    F/F  ;  Lck  -cre 
mice prevented us from analyzing the role of Runx1 at later 
stages of T cell development. Therefore, we used the   Cd4  -cre 
mice to inactivate the   Runx1   gene at the DP stage. Although 
we observed the intact   Runx1   fl  oxed allele in mature CD4      
and CD8      T cells from   Runx1    F/F  ;  Lck  -cre mice, suggesting se-
lection of cells that escaped deletion (  14  ), Cre-mediated dele-
tion in CD4      and CD8      T cells from   Runx1    F/F  ;  Cd4  -cre was 
almost complete at the DNA and protein levels (unpublished 
data). Total thymocyte numbers and DP thymocyte devel-
opment were intact in   Runx1    F/F  ;  Cd4  -cre as compared with 
control   Runx1    F/F   mice, except that the level of TCR      in 
  Runx1    F/F  ;  Cd4  -cre DP thymocytes was lower than in controls 
(  Fig. 2, B and E  ), whereas the TCR      expression level in 
CD4SP was slightly lower and CD8SP cells had normal 
down-regulated CD25 to become icTCR          CD25         DN4 
thymocytes. 40  –  50% of icTCR           cells, which were either 
CD25      or CD25        , were in the S/G2/M phases in cell-
cycle analysis and actively incorporated BrdU during a 2-h 
pulse labeling (  Fig. 1, B and D  ; and not depicted), indicat-
ing that thymocytes selected through       selection underwent 
robust proliferation after they expressed icTCR      and were 
stimulated by preTCR signaling. In DN thymocytes from 
  Runx1    F/F  ;  Lck  -cre mice, a similar or slightly smaller fraction 
of CD25      cells expressed icTCR      protein. However, the 
number of CD25  lo/      icTCR           cells was severely reduced 
(  Fig. 1 B  ). The CD25     icTCR           cells exhibited an active 
cell-cycling status, as determined by both DAPI staining for 
DNA content and BrdU incorporation, whereas the residual 
CD25  lo/      icTCR       lo   DN4 cells displayed little proliferation 
(  Fig. 1 D  ; and not depicted). These fi  ndings indicate that 
Runx1-defi  cient CD25  hi   cells could be primed by preTCR 
signals during       selection similar to control DN3 cells. How-
ever, Runx1-defi  cient DN3 cells failed to continue prolif-
erating during transition from the DN3 to DN4 stages and, 
  Figure 1.     Runx1 requirement in the differentiation of DN thymocytes. (A) CD4 and CD8 expression in total thymocytes (top) and CD25 and CD44 
expression in CD4  lo/     CD8      TCR           thymocytes (bottom) from   Runx1  F/F ; Lck  -cre mice and littermate   Runx1  F/F   control mice. Percentages of cells are shown in 
the indicated gates. (B and C) CD25 and icTCR      (B) and icTCR      and  TCR        (C) in CD4  lo/     CD8      TCR           thymocytes are shown. Gates used for population 
defi  nition and frequencies of the gated population in CD4  lo/     CD8      TCR           thymocytes are indicated. (D) Incorporation of BrdU by the thymocyte sub-
populations defi  ned in B. Numbers indicate the percentages of BrdU      cells  defi  ned by the interval gates. (E) Absolute numbers of thymocytes in immature 
thymocyte subpopulations from   Runx1  F/F ; Lck  -cre mice (closed bars) and littermate   Runx1  F/F   mice (open bars) are shown. Data were averaged from fi  ve 
mice with standard deviations.     1948 THE ROLE OF RUNX PROTEINS IN T CELL DEVELOPMENT | Egawa et al.
as TCR  hi  HSA  lo  CD4     CD8         was reduced by eightfold com-
pared with control mice, whereas the CD8 mature thymo-
cyte number was less severely reduced (  Fig. 2 C  , bottom; and 
  Fig. 2 F  ). The CD4/CD8 ratio at the TCR       hi   HSA  lo   stage 
was reduced to 0.3 in   Runx1    F/F  ;  Cd4  -cre mice from 2.4 in 
control mice (  Fig. 2 C  ). Reduced mature thymocyte numbers 
were also observed in MHC class I  –  restricted HY TCR trans-
genic mice and MHC class II  –  restricted DO.11.10 TCR 
transgenic mice bred to   Runx1    F/F  ;  Cd4  -cre mice, as compared 
with the TCR transgenic mice in the wild-type   Runx1   back-
ground   (  Fig. S2 A  )  . 
  These results suggested that Runx1 could play an important 
role for both thymocyte positive selection and commitment 
to the CD4SP lineage. However, CD8SP mature thymocytes 
failed to be generated in      2m       /      ;  Runx1    F/F  ;  Cd4  -cre mice 
(  Fig. 2 D  ). Together with the fi  nding that the frequency of 
CD4     8         thymocytes was similar between   Runx1    F/F  ;  Cd4  -cre 
and control mice in the TCR       hi  HSA  hi   transitional population 
(  Fig. 2 C  , top), the reduction of CD4SP thymocytes in the 
absence of Runx1 was therefore not caused by redirection of 
TCR      expression (unpublished data).   A fraction of DP thy-
mocytes from   Runx1    F/F  ;  Cd4  -cre mice and the majority of   DP 
thymocytes from   Runx1    F/F  ;  Lck  -cre mice expressed CD25 at 
a low level (Fig. S1, available at http://www.jem.org/cgi/
content/full/jem.20070133/DC1). These results suggest that 
Runx1 is not necessary for the survival or maintenance of DP 
thymocytes but is necessary for completely silencing CD25 
expression and for full TCR      expression. In the thymus from 
  Runx1    F/F  ;  Cd4  -cre mice, however, there was a reduction in 
SP mature thymocytes in both the CD4 and CD8 lineages 
(  Fig. 2, A and F  ). During positive selection, thymocytes 
initially show a TCR       int  CD69      transitional phenotype im-
mediately after TCR stimulation by self-MHC and peptide 
regardless of MHC class I  –   or class II  –  restricted selection and 
become TCR       hi   cells, followed by down-regulation of CD69 
and CD24 (heat-stable antigen [HSA]). In the   Runx1    F/F  ;  Cd4  -
cre thymocytes, there was a threefold reduction in the num-
ber of TCR      int  CD69      cells, and the number of TCR      hi  HSA  lo   
thymocytes was reduced by fourfold (  Fig. 2 A  , middle and 
bottom). The number of CD4SP mature thymocytes defi  ned 
  Figure 2.     Runx1 is required for positive selection and maturation of CD4SP thymocytes. (A) Expression of CD4, CD8, TCR     , CD69, and HSA 
(CD24) in thymocytes from   Runx1  F/F ; Cd4  -cre and littermate   Runx1  F/F   mice (top) is shown. Percentages of cells are shown in the indicated gates. (B) TCR     
expression of total thymocytes from   Runx1  F/F ; Cd4  -cre (open histogram) and littermate   Runx1  F/F   (shaded histogram) mice. (C) CD4 and CD8 expression in 
thymocytes gated for TCR     hi HSA hi   (top) and TCR     hi HSA lo   (bottom) from   Runx1  F/F ; Cd4  -cre and littermate   Runx1  F/F   mice. Percentages of CD4    CD8        thymo-
cytes in the gated rectangles are shown. (D) Development of CD4SP and CD8SP thymocytes in   Runx1  F/F ; Cd4  -cre and littermate   Runx1  F/F ; Cd4 -cre;    b 2m      /     
mice. The percentages of CD4SP and CD8SP mature thymocytes are shown. (E and F) The absolute numbers of total thymocytes and DP thymocytes (E) 
and mature thymocyte subpopulations (F) are shown as the mean and standard deviation from 4  –  10 mice with the indicated genotypes. Statistical differ-
ences were tested by the Student  ’  s   t   test. *, P       0.05; **, P       0.01.   JEM VOL. 204, August 6, 2007 
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in the spleen and lymph nodes from   Runx1    F/F  ;  Cd4  -cre mice 
remained severely reduced, whereas the CD8      T cell num-
ber was unaff  ected (  Fig. 3 B  ). Interestingly, the frequency of 
Foxp3      regulatory T cells was markedly increased in  Runx1    F/F  ;
  Cd4  -cre mice (  Fig. 3 C  ). Approximately 50% of peripheral 
CD4      T cells from   Runx1    F/F  ;  Cd4  -cre mice were Foxp3     , com-
pared with 15% of CD4      T cells from control mice (  Fig. 3 C  ). 
Runx1-defi  cient Foxp3      cells expressed a slightly lower level 
of Foxp3 and a normal level of CD25 compared with con-
trol mice, whereas a majority of Foxp3        CD4      T cells from 
  Runx1    F/F  ;  Cd4  -cre mice expressed CD25 at an intermediate 
level. Because the absolute number of Foxp3      regulatory 
T cells was only slightly reduced compared with control mice 
(unpublished data), the overall reduction of CD4      T cells in 
  Runx1    F/F  ;  Cd4  -cre mice was most likely caused by compromised 
homeostasis of Foxp3         conventional T cells. 
  To determine if the reduced CD4      T cell number was 
caused by impaired peripheral expansion of mature CD4      
T cells, we examined the proportion of peripheral T cell 
that entered S phase by measuring BrdU incorporation over 
a 72-h period (  Fig. 3 D  ). BrdU incorporation by CD19      B 
CD4SP thymocytes to the CD8SP lineage. Instead, it is likely 
that maturation or survival of committed CD4SP thymocytes 
is dependent on Runx1. The number of Foxp3      regulatory 
T cells was slightly reduced but was not as severely aff  ected as 
the number of Foxp3         CD4      T cells (unpublished data). 
  To determine whether Runx1 is involved in negative 
selection,   Runx1    F/F  ;  Cd4  -cre mice were crossed to DO11.10 
TCR transgenic mice in the I-A  d   MHC background, and thy-
mocyte apoptosis was examined upon incubation with OVA 
peptide and antigen-presenting cells. No diff   erence in the 
number of cells undergoing apoptosis was detected between 
  Runx1    F/F  ;  Cd4  -cre and control thymocytes, indicating that 
Runx1 is not required for negative selection (Fig. S2 B). 
  Runx1 is required for homeostasis of mature CD4     T cells 
but not of CD8     T cells 
  We next examined the development of TCR           cells in 
the periphery of   Runx1    F/F  ;  Cd4  -cre mice. In the spleen and 
lymph nodes, the CD4/CD8 ratio was further reduced to 
0.15 in   Runx1    F/F  ;  Cd4  -cre mice as compared with 1.6 in con-
trol mice (  Fig. 3 A  ).   The absolute number of CD4      T cells 
  Figure 3.     Runx1 regulates homeostasis of CD4     T cells in the periphery. (A) TCR      and CD19 expression (top) and CD4 and CD8 expression in gated 
TCR         cells (bottom). The percentages of populations gated in the rectangles are shown. (B) Numbers of TCR         cells,  CD4     T cells, and CD8      T cells from 
spleens are shown as the means and standard deviations from 4  –  10 mice of each indicated genotype. (C) Foxp3 and CD25 expression in CD4      T  cells. 
  Peripheral lymphocytes were stained for TCR     , CD4, CD25, and intracellular Foxp3, and Foxp3 and CD25 expression in TCR       CD4   CD8        cells is shown. 
The percentages of Foxp3      cells gated by the rectangles are shown. (D) BrdU incorporation by peripheral lymphocytes in   Runx1  F/F ; Cd4  -cre and littermate 
  Runx1  F/F   mice. Mice were administered BrdU for 72 h in drinking water, and percentages of BrdU      cells in gated B cells, CD4      T cells, and CD8      T cells are 
shown. Data shown represent three experiments with similar results. Statistical differences were tested by the Student  ’  s   t   test. *, P       0.05; **, P       0.01.   1950 THE ROLE OF RUNX PROTEINS IN T CELL DEVELOPMENT | Egawa et al.
cells. The contribution of CD45.2        Runx1    F/F  ;  Cd4  -cre cells 
to CD4SP thymocytes and to peripheral CD4      T cells was 
further decreased to 8 and 2%, respectively. Development of 
CD8SP thymocytes and mature CD8      T cells was also af-
fected by the ablation of Runx1 expression, but not nearly as 
severely as the development of CD4 lineage cells (  Fig. 4 B  ). 
Mature CD8SP thymocytes generated from   Runx1    F/F  ;  Cd4  -
cre DP cells were similar to the control CD45.1      cells in 
their ability to repopulate the peripheral T cell pool. In con-
trast, the contribution of Runx1-defi  cient CD4SP cells to 
the peripheral CD4 lineage T cell pool continued to erode 
during progression toward maturity (  Fig. 4, B and C  ). 
  Expression of IL-7R     is impaired in thymocytes 
and CD4     T cells in the absence of Runx1 
  Earlier studies have suggested that both suboptimal TCR  –
  MHC interactions and cytokine signals mediated by IL-7 are 
indispensable for the survival of naive T cells in the periphery 
(  21, 22  ) . We hypothesized that the reduction of CD4      ma-
ture thymocytes and T cells in the absence of Runx1 could 
be caused by compromised survival because of loss or reduc-
tion of survival signals. To test this hypothesis, we examined 
expression of IL-7R      in the Runx1-defi  cient thymocytes 
and peripheral T cells (  Fig. 5 A  ).   In control mice, IL-7R      
expression was detected in a fraction of TCR       int  CD69      and 
in all TCR       hi  CD69      thymocytes after positive selection. 
lymphocytes was similar between   Runx1    F/F  ;  Cd4  -cre and con-
trol mice. In control   Runx1    F/F   mice, an approximately similar 
proportion of CD4      and CD8      T cells was labeled by BrdU. 
However, approximately threefold more CD4      T cells were 
labeled in   Runx1    F/F  ;  Cd4  -cre mice than in control mice. This 
diff  erence was confi  ned to CD4 lineage T cells, indicating 
that Runx1-defi  cient peripheral CD4      T cells undergo ho-
meostatic expansion more actively than CD8      T cells but fail 
to restore this cellular compartment. These results suggest that 
the reduced CD4      T cell number is caused by accelerated cell 
death rather than compromised homeostatic proliferation. 
  To determine if the reduction of CD4      T cells was 
mainly caused by a specifi  c impairment in maturation and 
homeostasis in the CD4 lineage and to quantitate defects 
caused by Runx1 inactivation during T cell development, 
we analyzed mixed bone marrow chimeric mice that had 
been reconstituted with a 1:1 mixture of CD45.1 wild-type 
and CD45.2   Runx1    F/F  ;  Cd4  -cre or control   Runx1    F/F   bone 
marrow cells (  Fig. 4  ).   In DN thymocytes, in which Runx1 
was not inactivated by   Cd4  -cre, and in DP thymocytes, con-
tribution of CD45.2      cells was     50%, indicating that Runx1 
is not required for maintenance of DP thymocytes. In 
TCR       int  CD69      thymocytes, found immediately after posi-
tive selection, the contribution of Runx1-defi  cient CD45.2      
cells was reduced to 30%, whereas control CD45.2      cells 
were found in numbers equivalent to CD45.1      wild-type 
  Figure 4.     Quantitative analysis of precursor activity of Runx1-defi  cient thymocytes by a competitive repopulation assay. (A) Strategy for 
generation of mixed bone chimeras with CD45.2      bone marrow cells from   Runx1  F/F ; Cd4-  cre (Mut) or littermate control   Cd4-  cre (WT) mice. CD45.2      bone 
marrow cells mixed with wild-type CD45.2         (CD45.1; Comp) competitor bone marrow cells at the ratio of 1:1 were transferred into lethally irradiated 
Rag2      /      hosts. T cell development was analyzed 10  –  12 wk after transplantation. (B) Contribution of CD45.2      bone marrow cells at different stages of 
T cell development. Reconstituted thymocytes or lymph node cells were analyzed for frequency of CD45.2     -expressing cells in populations defi  ned by CD4, 
CD8, TCR     , and CD69 expression. (C) Relative T cell precursor potential of Runx1-defi  cient thymocytes, as determined in the competitive repopulation 
assay. The values for T cell precursor potential in the absence of Runx1 were normalized with the precursor potential of thymocytes derived from CD45.2     
control bone marrow cells, as described in Materials and methods.     JEM VOL. 204, August 6, 2007 
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that Runx1 and Runx3 together regulate its expression in 
these cells (unpublished data). Real-time RT-PCR analysis 
showed that the amount of   Il7r   mRNA in CD4SP thymo-
cytes was reduced by approximately fourfold in   Runx1    F/F  ;
  Cd4  -cre mice compared with control mice, whereas the tran-
script level was slightly lower but not statistically diff  erent in 
CD8SP thymocytes of   Runx1    F/F  ;  Cd4  -cre versus control mice 
(  Fig. 5 C  ). This fi  nding suggests that the reduced level of 
IL-7R      in Runx1-defi  cient CD4  +   T cells is caused, at least 
in part, by its attenuated transcription. 
  To examine the ability of CD4  +   T cells from   Runx1    F/F  ;
  Cd4  -cre mice to respond to IL-7, we initially examined 
whether recombinant IL-7 was able to support survival of 
mature T cells from   Runx1    F/F  ;  Cd4  -cre and control mice 
(Fig. S3, A and B, available at http://www.jem.org/cgi/
content/full/jem.20070133/DC1). Approximately 60 or 80% 
of CD4  +   and CD8  +   T cells from wild-type mice survived in 
media for 48 h, and their survival was improved to nearly 
100% in the presence of IL-7. CD8  +   T cells from   Runx1    F/F  ;
  Cd4  -cre mice survived similarly to wild-type CD8  +   T cells 
either in the presence or absence of IL-7. In contrast, the 
viability of CD4  +   T cells from   Runx1    F/F  ;  Cd4  -cre mice 
was substantially lower compared with wild-type CD4  +   T 
cells or Runx1-defi  cient CD8  +   T cells. Only 50% of input 
Runx1-defi  cient CD4  +   T cells survived after 2 h of incu-
bation, suggesting that a large fraction of CD4  +   T cells from 
Uniform expression of IL-7R      was also observed in both 
CD4 and CD8 lineages as thymocytes further matured to 
the TCR       hi  CD69    −    stage and into peripheral naive T cells. 
IL-7R      expression was slightly decreased in TCR       int  CD69  +   
thymocytes from   Runx1    F/F  ;  Cd4  -cre mice compared with 
control mice. However, in TCR       hi  CD69  +   thymocytes, in 
which uniform IL-7R      up-regulation was observed in wild-
type mice, IL-7R      expression was considerably compro-
mised in the absence of Runx1. In the HSA  lo  /CD69    −    mature 
thymocyte population, IL-7R      expression in the absence of 
Runx1 remained low in CD4  +   cells but was almost normal 
in CD8  +   T cells. Similarly, lymph node CD4  +   T cells from 
  Runx1    F/F  ;  Cd4  -cre mice expressed a lower level of IL-7R      
than CD4  +   T cells from control mice, but CD8 lineage cells 
were unaff  ected (  Fig. 5 B  ). 
  In the absence of Runx1, reduced expression of IL-7R      
was observed in Foxp3    −   CD4  +   T cells but not in the Foxp3  +   
population. This result indicates that the IL-7R      down-reg-
ulation in the total CD4  +   T cell fraction from   Runx1    F/F  ;  Cd4  -
cre mice was not caused by a relative increase in Foxp3  +   T 
cells, which normally express a lower level of IL-7R      com-
pared with conventional T cells. DN2 and DN3 thymocytes 
from   Runx1    F/F  ;  Lck  -cre mice also expressed lower levels of 
IL-7R      compared with control mice (unpublished data). 
IL-7R      expression was slightly lower in CD8  +   T cells from 
  Runx3    F/F  ;  Cd4  -cre mice compared with control mice, suggesting 
  Figure 5.     IL-7R      expression in developing thymocytes and T cells from   Runx1    F/F  ;  Cd4  -cre mice. (A) IL-7R      (CD127) expression in thymocyte 
populations defi  ned by rectangles (top) from   Runx1  F/F   (dotted histograms) and   Runx1  F/F ; Cd4  -cre (open histograms) mice. (B) IL-7R      expression in CD4     
and CD8      lymph node T cells from   Runx1  F/F   (dotted histograms) and   Runx1  F/F ; Cd4  -cre (open histograms) mice. CD4      T cells were further subdivided into 
Foxp3      and Foxp3         populations, and IL-7R      expression in each subpopulation was compared between   Runx1  F/F   (dotted histograms) and   Runx1  F/F ; Cd4 -cre 
(open histograms) mice. Shaded histograms in A and B are isotype staining controls. (C) Real-time PCR analysis of   Il7r   mRNA expression in mature thy-
mocytes from   Runx1  F/F ; Cd4  -cre and control   Runx1  F/F   mice.   Il7r   mRNA expression levels are normalized to   Actb   mRNA levels in individual samples. The 
relative   Il7r   mRNA expression is shown as the mean and standard deviation from three independent samples. Statistical differences were verifi  ed by the 
Student ’ s   t   test. Flow cytometry data shown are representative of three to fi  ve mice.     1952 THE ROLE OF RUNX PROTEINS IN T CELL DEVELOPMENT | Egawa et al.
  Runx1 and Runx3 have a high degree of sequence simi-
larity, particularly within the DNA-binding   runt   domains 
and the C-terminal domain containing the VWRPY motif. 
A previous report demonstrated that CD4 derepression 
was enhanced when one   Runx1   allele was inactivated in 
Runx3-defi  cient mice, suggesting that Runx1 and Runx3 
may have at least partially redundant roles (  19  ). Runx1 and 
Runx3 mRNAs are both expressed in DP and CD8SP thy-
mocytes, although Runx3 expression is low in DP compared 
with CD8SP thymocytes or CD8      T cells (  14  ). It is therefore 
possible that phenotypes observed upon conditional inactiva-
tion of Runx1 or Runx3 are attenuated by compensation of 
Runx3 and Runx1, respectively. To test this hypothesis, we 
generated mice with   Runx1   and   Runx3   conditional alleles 
and the   Cd4  -cre transgene, thus inactivating both Runx1 
and Runx3 at the DP stage (  Fig. 7  ).   After inactivation of 
both Runx1 and Runx3, TCR      expression in DP thymo-
cytes was further down-regulated compared with   Runx1    F/F  ;
  Cd4  -cre mice (  Fig. 7 C  ). The number of CD69      thymo-
cytes was more substantially reduced in   Runx1    F/F  ;  Runx3    F/F  ; 
Cd4  -cre mice than in   Runx1    F/F  ;  Cd4  -cre mice (unpublished 
data). HSA  lo   mature thymocytes in the double-defi  cient 
mice were decreased by 20-fold and 5-fold as compared with 
wild-type and   Runx1    F/F  ;  Cd4  -cre mice, respectively (  Fig. 2 E 
and Fig. 7 A  ). Reduction of CD8      mature thymocytes 
was much more striking in the double-defi  cient mice than 
in   Runx1    F/F  ;  Cd4  -cre or   Runx3    F/F  ;  Cd4  -cre animals (  Fig. 7 B  ). 
CD8      TCR       hi  HSA  lo   thymocytes were considerably reduced 
in   Runx1    F/F  ;  Runx3    F/F  ;  Cd4  -cre mice as compared with 
  Runx1    F/     Runx3    F/F  ;  Cd4  -cre mice. Furthermore, the remain-
ing CD8      mature thymocytes and CD8      peripheral T cells 
from the double-defi  cient mice had normal CD4 silenc-
ing, and many of them expressed CD103, whereas almost 
all CD8      mature thymocytes derepressed CD4 expression 
  Runx1    F/F  ;  Cd4  -cre mice were already predisposed to die in vivo 
or at a very early point in the culture. The frequency of 
Foxp3      cells among total CD4      T cells from   Runx1    F/F  ;  Cd4  -
cre mice remained unchanged over the fi  rst 2 h of incuba-
tion (unpublished data). In control samples, the Foxp3      cell 
number declined by twofold at 2 h, whereas the number of 
Foxp3        CD4  +   cells remained unchanged. These results sug-
gest that the diff  erential survival of CD4      T cells between 
Runx1  F/F  ;  Cd4  -cre and control mice is caused by a combina-
tion of preferential cell death of Foxp3         cells and potentially 
normal cell death of the enriched Foxp3      cells. At 48 h, only 
20% of the input number of CD4      T cells survived in the 
absence of Runx1. In addition, an exogenous IL-7 addition 
to the culture had little eff  ect on the survival of CD4      T cells 
from   Runx1    F/F  ;  Cd4  -cre mice. After overnight incubation 
in the presence of IL-7, bcl-2 was up-regulated in a dose-
  dependent manner in CD4      and CD8      T cells from wild-
type mice and in CD8      T cells from   Runx1    F/F  ;  Cd4  -cre mice 
(Fig. S3 C). In contrast, there was little up-regulation of bcl-2 
in Runx1-defi  cient CD4      T cells. These results indicate that 
incomplete IL-7R      expression results in compromised in 
  vitro survival of CD4      T cells from   Runx1    F/F  ;  Cd4  -cre mice. 
Breeding of   Runx1    F/F  ;  Cd4  -cre to IL-7R      transgenic mice (  23  ) 
resulted in an increased CD4/CD8 ratio, but the increase in 
CD4      T cells was modest, whereas there was a reduction in 
CD8      T cells, presumably because of competition for cyto-
kines (Fig. S3, D and E). This suggests that the level of IL-7R 
is not the only factor limiting the number of CD4      T cells in 
the absence of Runx1. 
  T cell  –  specifi  c Runx3 inactivation causes a reduction 
in CD8SP cells 
  To further study the function of Runx3 during thymocyte 
development, we next examined Runx3 conditional knock-
out mice crossed to   Cd4  -cre transgenic mice. After inacti-
vation of Runx3 at the DP stage, CD4 was derepressed in 
CD8      mature thymocytes, as previously observed in CD8      
mature thymocytes derived from Runx3-defi  cient hema-
topoietic progenitors (  Fig. 6 A  ) (  14  ).   CD8 expression in 
CD8      mature thymocytes, but not in DP thymocytes, was 
slightly reduced, suggesting that Runx3 contributes to CD8 
expression in positively selected thymocytes transiting from 
the CD4     8  lo   to the CD8SP stage (  Fig. 6 B  ). CD103/inte-
grin      E expression was lost in mature CD8      thymocytes 
(Fig. S4, available at http://www.jem.org/cgi/content/
full/jem.20070133/DC1), consistent with previous results 
using T cells derived from Runx3-defi  cient fetal liver cells 
(  24  ). The CD8      mature thymocyte number was decreased 
by 25%, whereas the number of CD4SP thymocytes did 
not signifi  cantly change compared with control mice (  Fig. 
6 A and Fig. 3 B  ). The number of CD4SP thymocytes re-
mained unchanged in   Runx3    F/F  ;  Cd4  -cre;  I-A         /       mice com-
pared with   Runx3    F/+  ;  Cd4  -cre;  I-A         /       mice, indicating that 
the reduced CD8SP thymocyte number was not caused 
by lineage redirection when Runx3 alone was inactivated 
(unpublished data). 
  Figure 6.     Runx3 inactivation at the DP stage results in reduced 
CD8SP thymocytes. (A) CD4 and CD8 expression in total thymocytes 
(top) and gated TCR     hi HSA lo   thymocytes (bottom) from   Runx3  F/F ; Cd4 -cre 
and littermate   Runx3  F/F   mice. Frequencies of mature thymocyte popula-
tions are shown. (B) CD8 expression in TCR     hi HSA lo   thymocytes  from 
  Runx3  F/F ; Cd4  -cre (open histogram) and littermate   Runx3  F/F   (shaded 
 histogram)  mice.   JEM VOL. 204, August 6, 2007 
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requires functional Runx protein activity supplied by either 
Runx1 or Runx3. 
  Runx3 expression in CD8SP cells is regulated at both 
transcriptional and posttranscriptional levels 
  In peripheral TCR           cells, Runx3 mRNA levels were 
similar in CD4      and CD8      T cells (  14  ). However, Runx3 
protein was predominantly expressed in CD8SP medullary 
thymocytes and CD8      T cells (  Fig. 8, A and C  ) and was not 
detectable in CD4SP or CD4      T cells.   All three   Runx   genes 
have distal and proximal promoters, although   Runx2   has 
multiple transcription and translation initiation sites for both 
of the promoters (  25  ). For   Runx1   and   Runx3  , transcripts 
from the distal and proximal promoters encode protein prod-
ucts that have unique 19  –   or 6  –  amino-acid N-terminal se-
quences, respectively (  Fig. 8 B  ). We performed RT-PCR 
analysis using primers that distinguish the two transcripts for 
Runx3 to determine whether Runx3 promoter usage was 
diff  erent between CD4SP and CD8SP cells (  Fig. 8 E  ). We 
found that the Runx3 transcript derived from the distal pro-
moter was exclusively expressed in the CD8SwP population, 
but not in the CD4SP population or DN and DP thymo-
cytes. To examine if Runx3 protein detected in CD8      T 
cells is derived from the distal transcript, we generated an anti-
serum against the N-terminal 19 amino acids and performed 
immunoblotting using lysates of CD4      and CD8      T cells. 
and lacked CD103 expression in   Runx1    F/   ;Runx3  F/F  ;  Cd4  -
cre mice (  Fig. 7, B and D  ). These CD4        CD8      mature thy-
mocytes from   Runx1    F/F    Runx3    F/F  ;  Cd4  -cre mice retained the 
intact Runx3-fl  oxed allele (  Fig. 7 E  ), suggesting that these 
cells escaped from Cre-mediated excision of the Runx3 al-
leles and that development of the CD8SP phenotype cells 
  Figure 7.     Runx proteins are required for the development of CD8     
mature thymocytes. (A and B) CD4 and CD8 expression in total thymo-
cytes (A, top) and gated TCR     hi HSA hi   (B, top) or TCR     hi HSA lo   (B,  bottom) 
thymocytes, and TCR      and HSA expression in total thymocytes (A, bottom) 
from mice with the indicated genotypes. Percentages within the gated 
populations are shown. (C) Surface TCR      expression in total thymocytes 
from   Runx1  F/F   (shaded histogram),   Runx1  F/F ; Cd4  -cre (dotted histogram), 
and   Runx1  F/F ; Runx3  F/F ; Cd4  -cre (open histogram) mice. (D) CD103 expres-
sion in CD8  +   mature thymocytes from wild-type (shaded histogram), 
  Runx1  F/  ; Runx3  F/F ; Cd4  -cre (dotted histogram), and   Runx1  F/F ; Runx3  F/F ; Cd4 -
cre (open histogram) mice. The gated CD8  +   populations are defi  ned in B 
(bottom). (E) Genomic PCR analysis to detect Cre-mediated recombination 
of the Runx3-fl  oxed allele in CD4SP and CD8SP thymocytes from   Runx1  F/F ;
  Runx3  F/F ; Cd4  -cre mice. Genomic DNA was prepared from sorted mature 
thymocyte populations, and PCR was performed using primers for the 
intact Runx3-fl  oxed allele and the recombined Runx3 allele. Positions of 
individual PCR products are indicated as lines on the right side.     
  Figure 8.     CD8SP cells use the distal promoter of   Runx3  . (A) Runx3 
protein is predominantly expressed in CD8SP thymocytes in the thymic 
medulla. Frozen sections from a wild-type thymus were stained for CD4 
(blue), CD8 (red), and Runx3 (green). Arrowheads indicate cells expressing 
both CD8 and Runx3. (B) Genomic organization of exons encoding the 
different mouse Runx3 isoforms. White boxes and fi  lled boxes depict 
  coding and noncoding sequences, respectively. (C) Western blot analysis 
of total Runx3 expression in CD4      and  CD8     T cells from lymph nodes. 
Immunoblot against HMG1 was used as a loading control. (D) Western blot 
analysis to detect the distal promoter-derived Runx3 protein in CD8     
T cells. (E) RT-PCR analysis of promoter-specifi  c Runx3 mRNA expression in 
different subsets of thymocytes and T cells. Numbers shown below each 
lane are the relative amount of   Actb   cDNA determined by real-time PCR.     1954 THE ROLE OF RUNX PROTEINS IN T CELL DEVELOPMENT | Egawa et al.
observed in Runx1/Runx3 double-defi  cient  thymocytes 
with considerably low expression of TCR      at the DP stage. 
These fi  ndings suggest that impaired positive selection may 
be caused by insuffi   cient TCR levels. We were unable to de-
tect diff  erences in the expression of proximal signaling mole-
cules, including Lck,      -associated protein of 70 kD, Vav-1, 
and phospholipase C      1 in DP thymocytes from   Runx1    F/F  ;
  Cd4-  cre mice (unpublished data). Bim induction after TCR 
stimulation of DP thymocytes was not increased (unpub-
lished data). 
  During thymocyte maturation, CD4SP lineage cells were 
specifi  cally lost between the TCR      hi  HSA  hi   and TCR      hi  HSA  lo   
stages after   Runx1   inactivation at the DP stage, but matura-
tion of CD8SP cells was less severely aff  ected. This observa-
tion suggests that the specifi  c reduction of CD4SP cells most 
likely occurs after positive selection. In CD8SP cells, Runx3 
may compensate for the Runx1 defi  ciency or replace Runx1 
requirements after positive selection. 
  The IL-7/IL-7R signal is essential for early thymocyte 
development (  22, 29  –  32  ). It has been broadly recognized 
that IL-7R      is also required for the survival of mature thy-
mocytes and naive and memory T cells (  21, 33  ). Develop-
ment of CD8SP thymocytes is considered to be more sensitive 
to IL-7R signaling than that of CD4SP cells (  34  –  36  ). How-
ever, the earlier studies did not rule out that IL-7R signaling 
is required for CD4SP development. Regulation of IL-7R      
expression is critical for effi   cient utilization of IL-7, a cyto-
kine that is not abundantly expressed in the microenviron-
ment (  23  ). Exogenous IL-7 treatment of mature T cells leads 
to IL-7R      down-regulation that is thought to contribute 
to more effi   cient distribution of the eff  ect of IL-7, because 
loss of this negative feedback leads to a reduced number of 
peripheral mature T cells and to compromised thymocyte 
development (  37  ). 
  The reduction of CD4SP thymocytes and of peripheral 
CD4      T cells in   Runx1    F/F  ;  Cd4-  cre mice coincided with the 
reduced expression of IL-7R     , suggesting that Runx1-
  dependent IL-7R      expression plays an important role in matu-
ration and homeostasis of this lineage, while Runx3 could 
play a similar role in CD8SP cells. One potential explanation 
for the reduction of CD4SP cells relative to CD8SP cells in 
  Runx1    F/F  ;  Cd4  -cre mice is that CD8SP cells with almost nor-
mal expression of IL-7R      preferentially use the limiting 
amount of IL-7, resulting in their better survival. This could 
alter the CD4/CD8 ratio in HSA  lo   mature thymocytes and in 
the peripheral T cells despite the almost normal CD4/CD8 
ratio in the intermediate HSA  hi   thymocytes. This hypothesis 
is consistent with our observation that the CD4/CD8 ratio 
in the periphery was not altered in   Cbfb    F/F  ;Cd4    -cre mice, 
in which there was reduced expression of IL-7R      in both 
CD4      and CD8      T cells (unpublished data). The reduction 
of total CD4      T cells in the absence of Runx1 was caused by 
a specifi  c loss of Foxp3    −    conventional CD4      T cells, which 
resulted in a high frequency, but a relatively normal number, 
of Foxp3      regulatory T cells. IL-7R      expression was normal 
in Runx1-defi  cient Foxp3      cells in comparison to control 
We detected Runx3 protein derived from the distal promoter 
in CD8      T cells (  Fig. 8 D  ). Although we cannot rule out the 
possibility that a fraction of Runx3 protein expressed in 
CD8      T cells is derived from the proximal transcript, our 
data suggest that CD8      T cells, but not CD4      T cells, specif-
ically use the distal promoter of   Runx3   and that the transcript 
produced is then preferentially translated. 
    DISCUSSION   
  Diff  erential expression of the CD4 and CD8 glycoproteins 
during thymocyte diff  erentiation marks diff  erent precursor 
stages and mature populations with diff  erent eff  ector func-
tions. Because   Cd4   expression is primarily dependent on its 
silencer activity (  11, 12  ), we had hypothesized that factors 
that contribute to regulation of the   Cd4   silencer could also 
play important roles in T cell diff  erentiation programs, par-
ticularly during specifi  cation of the CD8SP lineage. Mem-
bers of the Runx family of transcription factors are thus far 
the only molecules known to regulate the function of the 
  Cd4   silencer. Runx1 inactivation early in thymocyte diff  er-
entiation resulted not only in partial derepression of   Cd4   but 
also in arrest of thymocyte diff  erentiation between the DN3 
and DN4 stages (  14  ). The DN3  –  DN4 transition requires a 
robust proliferation phase that is induced by preTCR signals 
during       selection. After   Runx1   inactivation with the   Lck  -cre 
transgene, DN3 cells expressing icTCR      were only slightly 
reduced in numbers compared with the wild type and dis-
played an active cell-cycle status, suggesting that expression 
of TCR      and preTCR signaling components were unlikely 
to be defective. However, proliferation was decelerated at 
the DN4 stage, during which wild-type thymocytes continue 
to proliferate. This fi  nding is consistent with the reduced 
thymocyte cellularity observed in   Runx1    F/F  ;  Lck-  cre mice but 
not in   Runx1    F/F  ;  Cd4-  cre mice. 
  The loss of proliferation of DN4 thymocytes in   Runx1    F/F  ;
  Lck  -cre mice was accompanied by reduced expression of 
icTCR     . Such a reduction was also observed in DP thymo-
cytes from   Runx1    F/F  ;  Cd4  -cre mice and, more remarkably, in 
those from Runx1/Runx3 doubly conditional knockout 
mice bred to   Cd4  -cre. Runx binding sites are found in the 
  Tcrb   enhancer (E     ) (  26, 27  ), and Runx1 inactivation may re-
sult in incomplete   Tcrb   expression that is most remarkable at 
the DN4 stage. TCR      expression cannot be maintained in 
DN4 cells without E      activity even after successful V to DJ 
rearrangement occurs and TCR      protein is expressed at the 
DN2 and DN3 stages (  28  ). After inactivation of   Runx1   by 
the   Lck  -cre transgene, whose expression is initiated in DN2 
cells, expression of the protein may persist long enough to 
initiate   Tcrb   rearrangement and allow icTCR      expression in 
DN2/DN3, but not in DN4, thymocytes. It is also possible 
that Runx1 regulates other targets that are necessary for the 
survival or proliferation of DN4 thymocytes. 
  After   Cd4  -cre  –  mediated   Runx1   inactivation at the DP 
stage, we observed a moderate reduction of TCR       int  CD69      
thymocytes undergoing positive selection. A substantially 
more severe reduction of TCR       int  CD69  +   thymocytes was JEM VOL. 204, August 6, 2007 
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its expression level was not as high as that in CD8 mature 
thymocytes (Fig. S5, available at http://www.jem.org/cgi/
content/full/jem.20070133/DC1). Runx3 up-regulation thus 
seems to occur at a later stage than ThPOK up-regulation. 
This implies that MHC class I  –  selected CD4     CD8  lo   cells, 
which do not express a high level of ThPOK, remain un-
committed until they pass through the CD4     CD8  lo   stage and 
that CD4 and CD8 lineage commitment may then be initi-
ated at diff  erent developmental stages. Alternatively, a ge-
netic program for CD8 lineage commitment may be already 
initiated in the CD4     CD8  lo   transient population before 
Runx3 up-regulation and CD8      reactivation. The identifi  -
cation of factors that regulate Runx3 expression in develop-
ing CD8SP cells will allow us to propose a better working 
model for mechanisms of CD8 lineage commitment. 
  In conclusion, Runx proteins play important roles in thy-
mocyte developmental programs. Among the three Runx 
transcription factors, Runx1 and Runx3 are required for 
stage- and lineage-specifi  c functions. It will be important to 
identify target genes that contribute to the phenotypes ob-
served in the Runx1 and Runx3 conditional knockout mice. 
Future studies will also clarify how Runx1 and Runx3 func-
tions overlap and how diff  erent Runx proteins diff  erentially 
control gene expression. 
  MATERIALS AND METHODS 
  Mouse strains.     Generation of Runx1 and Runx3 conditional knockout 
mice was previously described (  14, 38  ). Runx1-fl  ox and Runx3-fl  ox mice 
were bred with   Cd4  -cre or   Lck  -cre transgenic mice (  39  ) to inactivate Runx1 
or Runx3 at diff  erent stages of T cell development.        2m  - and   I-A    –  defi  cient 
mice were purchased from Taconic. IL-7R      transgenic mice were provided 
by A. Singer (National Cancer Institute, Bethesda, MD) (  23  ). All mice used 
in the experiments were housed in a specifi  c pathogen-free animal facility at 
the Skirball Institute, and experiments were performed in accordance with 
a protocol approved by the Institutional Animal Care and Use Committee at 
the New York University School of Medicine. 
  Generation of mixed bone marrow chimera for quantifi  cation of 
precursor activity.     A mixture of 10  6   CD45.1      wild-type and 10  6   of either 
CD45.2        Runx1    F/F  ;  Cd4  -cre or CD45.2        Runx1     /   ;  Cd4  -cre bone marrow 
cells was transferred to lethally irradiated   Rag2         /       hosts, as previously de-
scribed (  40  ). The precursor potential of developing thymocytes derived from 
CD45.2 bone marrow cells relative to those derived from CD45.1      wild-
type bone marrow was calculated based on contribution of CD45.2      cells 
between the two stages of T cell diff   erentiation as follows: P(A  →  B) = 
B2(100   −   A2)/(A2[100   −   B2]), where P(A  →  B) is a precursor potential of 
CD45.2      cells proceeding from a developmental stage A to a stage B relative 
to CD45.2         cells, A2 is the percentage of CD45.2      cells at stage A, and B2 
is the percentage of 45.2      cells at the subsequent stage B. 
  Flow cytometry.     Staining of surface antigens was performed as previously 
described (40). Antibodies were purchased from either BD Biosciences or 
eBioscience. For intracellular TCR      staining, cells were stained for surface 
antigens, fi   xed with Cytofi   x/Cytoperm solution (BD Biosciences), and 
stained with the anti-TCR      antibody diluted in Perm/Wash buff  er (BD 
Biosciences). Intracellular Foxp3 staining was performed according to the 
manufacturer  ’  s instruction (eBioscience). For cell-cycle analysis, cells were 
fi  xed and stained with DAPI. Data were collected with a cytometer (LSRII; 
BD Biosciences) using FACSDiva software (BD Biosciences) and were ana-
lyzed with FlowJo software (TreeStar, Inc.). Cell sorting was performed on 
a cell sorter (MoFlo; DakoCytomation). 
Foxp3      cells. This fi  nding suggested that Foxp3      T reg cells 
might be able to use IL-7 in the microenvironment to restore 
their numbers in the peripheral lymphoid organs similarly to 
CD8      T cells, or that homeostasis of Foxp3      cells might be 
dependent on other cytokines, such as IL-2. Because IL-7R      
expression was reduced in Foxp3      cells from   Cbfb    F/F  ;Cd4    -
cre mice (unpublished data), other Runx proteins appear to 
contribute to IL-7R      expression in the population. Future 
experiments will be required to clarify how Runx proteins 
contribute to the development and homeostasis of Foxp3      
regulatory T cells. We also tested the possibility that en-
hanced activation-induced cell death might result in reduced 
CD4      T cells in the periphery, but apoptosis after secondary 
in vitro TCR stimulation was not increased in CD4      T cells 
from   Runx1    F/F  ;  Cd4-  cre mice (unpublished data). 
  Runx3 inactivation at the DP stage caused reduction of 
CD8SP mature thymocytes, yet we did not observe remark-
ably altered IL-7R      expression, possibly because of com-
pensation from Runx1 expressed in the CD8 lineage cells. 
Runx3 inactivation alone did not result in redirection of 
MHC class I  –  selected thymocytes to the CD4SP phenotype 
(unpublished data). 
  During thymocyte diff  erentiation, a high level expression 
of Runx3 is detected only in CD8SP thymocytes and not in 
CD4SP thymocytes, whereas Runx1 expression is detected 
in both CD4SP and CD8SP populations, as well as in DP 
thymocytes (  14, 18  ). Because few CD8SP thymocytes that 
likely lost all Runx function developed in the Runx1/Runx3 
doubly conditional knockout mice, Runx protein functions 
appear to be required for development of CD8SP thymo-
cytes. Unfortunately, because of an escape of cells that failed 
to excise either Runx1 or Runx3, we were unable to deter-
mine the mechanism by which CD8SP development was 
impaired in the absence of any Runx protein function. The 
reduced CD8SP generation was possibly caused by redirec-
tion of MHC class I  –  selected thymocytes to the CD4SP pop-
ulation, to defective Runx protein function causing both 
CD4 derepression and lack of CD8 reactivation after positive 
selection, or to impaired survival or maturation of CD8SP 
thymocytes immediately after positive selection. 
  It has been reported that overexpression of a dominant-
negative form of Runx caused lineage redirection in vitro 
(  18  ). Expression of the dominant-negative Runx resulted in 
severe reduction of CD8SP thymocytes and generation of 
CD4SP cells instead after transient agonist stimulation of DP 
thymocytes. This result is also consistent with the importance 
of Runx protein function in the generation and commitment 
of CD8SP thymocytes. 
  Runx3 up-regulation and protein expression correlate 
with development of CD8SP cells and are indications tightly 
linked with CD8 lineage commitment. ThPOK expression, 
which is necessary and suffi   cient for commitment of CD4SP 
thymocytes, is robustly up-regulated in a CD4     CD8  lo   thy-
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  BrdU labeling.     For analysis of peripheral T cells, mice were injected i.p. 
with 1 mg BrdU (Sigma-Aldrich) and continuously administered BrdU in 
drinking water (0.8 mg/ml) for 72 h. For analysis of thymocytes, 1 mg BrdU 
was administered by i.p. injection 2 h before death. Surface staining and 
analysis were performed with a BrdU Flow Kit, according to the manufac-
turer  ’  s instruction (BD Biosciences). 
  Testing for cell survival.     Single-cell suspension of lymph node cells was 
prepared in RPMI 1640 supplemented with 10% fetal calf serum, sodium 
pyruvate, 2-mercaptoethanol, and antibiotics. Cells were cultured in media 
at 37  °  C with 5% CO  2   either in the presence or absence of recombinant 
mouse IL-7 (PeproTech) at the concentrations described in the fi  gure 
  legends. After incubation for diff  erent times, cells were stained for CD4, CD8, 
and TCR      on ice, incubated with propidium iodide and FITC  –  Annexin V 
(BD Biosciences) at room temperature for 15 min, and immediately analyzed 
by fl  ow cytometry. 
  RT-PCR.     RNA and cDNA from sorted thymocyte and T cell popu-
lations were prepared using TRI  zol   and Superscript II reverse-transcriptase 
(Invitrogen). Input cDNA was quantitated based on the amount to   Actb   cDNA 
determined by Taqman PCR, using the primers and probe as previously described 
(  40  ). For analysis of   Il7r   expression, real-time PCR was performed using iCycler 
and iQ SYBR reagent (Bio-Rad Laboratories). For analysis of Runx3 expres-
sion, PCR was performed with an Advantage GC2 PCR kit (CLONTECH 
Laboratories, Inc.). Primer sequences are as follows:   Il7r  -F, acacagtgcaaaccgctcg; 
  Il7r  -R, ctagccaggcatcttaagggtg;   Runx3   distal F, cgacatggcttccaacag;   Runx3   
proximal F, atgcgtattcccgtagacc; and   Runx3   common R, ccagctctccagagtcttc 
  Online supplemental material.     Fig. S1 shows ectopic CD25 expression in 
DP thymocytes from   Runx1    F/F  ;  Cd4  -cre and   Runx1    F/F  ;  Lck  -cre mice. Fig. S2 
shows thymocyte positive and negative selection in   Runx1    F/F  ;  Cd4  -cre mice 
with TCR transgenes. Fig. S3 shows in vitro survival of CD4      and CD8      
T cells from   Runx1    F/F  ;  Cd4  -cre mice. Fig. S4 shows CD103 expression in 
CD8SP cells from Runx3  F/F  ;  Cd4-  cre mice. Fig. S5 shows ThPOK and Runx3 
mRNA expression in developing thymocytes. Online supplemental material 
is available at http://www.jem.org/cgi/content/full/jem.20070133/DC1. 
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